View by type:
Articles (4257)
Everything you need to know about the brain-eating amoeba that’s killed three children in Kerala
Although deaths from amoebic meningoencephalitis are rare, they could become more common because of climate change.
River blindness and the black flies that cause it torment millions in west Africa. The “slash and clear” method is an effective way to eliminate them at source.
The allocation follows a Gavi Board decision in December 2023 to approve US$ 290 million funding for the “Big Catch-Up” initiative.
Meet the African scientists fighting the spread of mpox
Professor Dimie Ogoina was among the first to raise the alarm as mpox spread through Nigeria’s cities in 2017. VaccinesWork spoke to him and the DRC researchers tackling the latest outbreak.
Gavi and Côte d'Ivoire commit to a successful programmatic and financial transition
Côte d’Ivoire commits to fully finance its routine immunisation programme over the next five years to ensure sustainability beyond Gavi support.
How One Health can help ease climate-driven health crises
As extreme heat awareness rises, a One Health approach and robust adaptation strategies are essential for climate-resilient health systems.
How will Cote d'Ivoire roll out the malaria vaccine?
Yesterday, Côte d'Ivoire made history by becoming the first country to introduce the R21 malaria vaccine into its routine immunisation programme. We spoke to the country's EPI Director to find out how they plan to roll out this lifesaver.
Battling malaria, South Sudan anticipates roll-out of life-saving vaccines
As South Sudan prepares to deploy a new weapon in its fight against malaria, the R21 vaccine, Winnie Cirino surveys the parasitic disease’s foothold.
South Sudan Launches R21 Malaria Vaccine Rollout to Protect Children
In a historic move to combat the devastating impact of malaria, the Ministry of Health, in partnership with UNICEF and the World Health Organization and Gavi, The Vaccine Alliance, today launched the nationwide rollout of the R21 malaria vaccine…
Gavi receives top marks for aid transparency fifth year in a row
Gavi, the Vaccine Alliance, has been ranked in the ‘Very good’ category for the fifth time in the 2024 Publish What You Fund (PWYF) Index, a leading assessment of aid transparency.
Time to hope for a Lassa fever vaccine?
Lassa fever is brutal, deadly, has pandemic potential, and is only getting more dangerous as the world’s climate changes. A vaccine can’t come soon enough. Is the candidate currently in Phase 2 trials in West Africa on track for success?
Watching sports is good for you – thanks to its social bonding effects
Regularly watching sporting events – whether in person or on TV – is linked to higher wellbeing.